APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral GnRH Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral GnRH Drugs Market Outlook and Growth Opportunities 2026

29 December 2025190 pages

Choose your research edition.

Industry ResearchOral GnRH Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral GnRH Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Oral GnRH Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral GnRH Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral GnRH Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral GnRH Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral GnRH Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral GnRH Drugs market include Pfizer, Abbvie, Sumitomo Pharma, ObsEva, JW Pharmaceutical and ASKA Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral GnRH Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral GnRH Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral GnRH Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral GnRH Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral GnRH Drugs Segment by Company

Pfizer

Abbvie

Sumitomo Pharma

ObsEva

JW Pharmaceutical

ASKA Pharmaceutical

Oral GnRH Drugs Segment by Type

Relugolix

Linzagolix

Elagolix

Others

Oral GnRH Drugs Segment by Application

Menorrhagia

Uterine Fibroids

Endometriosis

Other

Oral GnRH Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oral GnRH Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral GnRH Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral GnRH Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Oral GnRH Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral GnRH Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral GnRH Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral GnRH Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral GnRH Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral GnRH Drugs industry.

Chapter 3: Detailed analysis of Oral GnRH Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral GnRH Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral GnRH Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral GnRH Drugs Industry Trends Table 2. Oral GnRH Drugs Industry Drivers Table 3. Oral GnRH Drugs Industry Opportunities and Challenges Table 4. Oral GnRH Drugs Industry Restraints Table 5. Global Oral GnRH Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral GnRH Drugs Revenue Share by Company (2021-2026) Table 7. Global Oral GnRH Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Oral GnRH Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Oral GnRH Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Oral GnRH Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral GnRH Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Oral GnRH Drugs Company, Product Type & Application Table 13. Global Oral GnRH Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral GnRH Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Relugolix Table 18. Significant Companies of Linzagolix Table 19. Significant Companies of Elagolix Table 20. Significant Companies of Others Table 21. Global Oral GnRH Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Oral GnRH Drugs Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Oral GnRH Drugs Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Oral GnRH Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Oral GnRH Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Oral GnRH Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Oral GnRH Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Oral GnRH Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Oral GnRH Drugs Sales Value Share by Type (2021-2026) Table 30. Global Oral GnRH Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Menorrhagia Table 32. Significant Companies of Uterine Fibroids Table 33. Significant Companies of Endometriosis Table 34. Significant Companies of Other Table 35. Global Oral GnRH Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Oral GnRH Drugs Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Oral GnRH Drugs Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Oral GnRH Drugs Sales Volume Share by Application (2021-2026) Table 39. Global Oral GnRH Drugs Sales Volume Share by Application (2027-2032) Table 40. Global Oral GnRH Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Oral GnRH Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Oral GnRH Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Oral GnRH Drugs Sales Value Share by Application (2021-2026) Table 44. Global Oral GnRH Drugs Sales Value Share by Application (2027-2032) Table 45. Global Oral GnRH Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Oral GnRH Drugs Sales by Region (2021-2026) & (K Units) Table 47. Global Oral GnRH Drugs Sales Market Share by Region (2021-2026) Table 48. Global Oral GnRH Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Oral GnRH Drugs Sales Market Share by Region (2027-2032) Table 50. Global Oral GnRH Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Oral GnRH Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Oral GnRH Drugs Sales Value Share by Region (2021-2026) Table 53. Global Oral GnRH Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Oral GnRH Drugs Sales Value Share by Region (2027-2032) Table 55. Global Oral GnRH Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Oral GnRH Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Oral GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Oral GnRH Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Oral GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 60. Global Oral GnRH Drugs Sales Market Share by Country (2021-2026) Table 61. Global Oral GnRH Drugs Sales by Country (2027-2032) & (K Units) Table 62. Global Oral GnRH Drugs Sales Market Share by Country (2027-2032) Table 63. Global Oral GnRH Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Oral GnRH Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global Oral GnRH Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Oral GnRH Drugs Sales Value Market Share by Country (2027-2032) Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Oral GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Pfizer Oral GnRH Drugs Product Portfolio Table 71. Pfizer Recent Development Table 72. Abbvie Company Information Table 73. Abbvie Business Overview Table 74. Abbvie Oral GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Abbvie Oral GnRH Drugs Product Portfolio Table 76. Abbvie Recent Development Table 77. Sumitomo Pharma Company Information Table 78. Sumitomo Pharma Business Overview Table 79. Sumitomo Pharma Oral GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sumitomo Pharma Oral GnRH Drugs Product Portfolio Table 81. Sumitomo Pharma Recent Development Table 82. ObsEva Company Information Table 83. ObsEva Business Overview Table 84. ObsEva Oral GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. ObsEva Oral GnRH Drugs Product Portfolio Table 86. ObsEva Recent Development Table 87. JW Pharmaceutical Company Information Table 88. JW Pharmaceutical Business Overview Table 89. JW Pharmaceutical Oral GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. JW Pharmaceutical Oral GnRH Drugs Product Portfolio Table 91. JW Pharmaceutical Recent Development Table 92. ASKA Pharmaceutical Company Information Table 93. ASKA Pharmaceutical Business Overview Table 94. ASKA Pharmaceutical Oral GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. ASKA Pharmaceutical Oral GnRH Drugs Product Portfolio Table 96. ASKA Pharmaceutical Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Oral GnRH Drugs Distributors List Table 100. Oral GnRH Drugs Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Oral GnRH Drugs Product Image Figure 2. Global Oral GnRH Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral GnRH Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral GnRH Drugs Sales (2021-2032) & (K Units) Figure 5. Global Oral GnRH Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Oral GnRH Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Relugolix Image Figure 10. Linzagolix Image Figure 11. Elagolix Image Figure 12. Others Image Figure 13. Global Oral GnRH Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Oral GnRH Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Oral GnRH Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Oral GnRH Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Oral GnRH Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Oral GnRH Drugs Sales Value Share by Type (2021-2032) Figure 19. Menorrhagia Image Figure 20. Uterine Fibroids Image Figure 21. Endometriosis Image Figure 22. Other Image Figure 23. Global Oral GnRH Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Oral GnRH Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Oral GnRH Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global Oral GnRH Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Oral GnRH Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Oral GnRH Drugs Sales Value Share by Application (2021-2032) Figure 29. Global Oral GnRH Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Oral GnRH Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Oral GnRH Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Oral GnRH Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Oral GnRH Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Oral GnRH Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Oral GnRH Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Oral GnRH Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Oral GnRH Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Oral GnRH Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Oral GnRH Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Oral GnRH Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Oral GnRH Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Oral GnRH Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Oral GnRH Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Oral GnRH Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Oral GnRH Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Relugolix
  • Linzagolix
  • Elagolix
  • Others
Applications
  • Menorrhagia
  • Uterine Fibroids
  • Endometriosis
  • Other
Companies covered
  • Pfizer
  • Abbvie
  • Sumitomo Pharma
  • ObsEva
  • JW Pharmaceutical
  • ASKA Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral GnRH Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Oral GnRH Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Oral GnRH Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral GnRH Drugs Market Dynamics
  1. 2.1 Oral GnRH Drugs Industry Trends
  2. 2.2 Oral GnRH Drugs Industry Drivers
  3. 2.3 Oral GnRH Drugs Industry Opportunities and Challenges
  4. 2.4 Oral GnRH Drugs Industry Restraints
3 Oral GnRH Drugs Market by Company
  1. 3.1 Global Oral GnRH Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Oral GnRH Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Oral GnRH Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral GnRH Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Oral GnRH Drugs Company Ranking (2024-2026)
  6. 3.6 Global Oral GnRH Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral GnRH Drugs Company Product Type and Application
  8. 3.8 Global Oral GnRH Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral GnRH Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral GnRH Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral GnRH Drugs Market by Type
  1. 4.1 Oral GnRH Drugs Type Introduction
  2. 4.1.1 Relugolix
  3. 4.1.2 Linzagolix
  4. 4.1.3 Elagolix
  5. 4.1.4 Others
  6. 4.2 Global Oral GnRH Drugs Sales Volume by Type
  7. 4.2.1 Global Oral GnRH Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Oral GnRH Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Oral GnRH Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Oral GnRH Drugs Sales Value by Type
  11. 4.3.1 Global Oral GnRH Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Oral GnRH Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Oral GnRH Drugs Sales Value Share by Type (2021-2032)
5 Oral GnRH Drugs Market by Application
  1. 5.1 Oral GnRH Drugs Application Introduction
  2. 5.1.1 Menorrhagia
  3. 5.1.2 Uterine Fibroids
  4. 5.1.3 Endometriosis
  5. 5.1.4 Other
  6. 5.2 Global Oral GnRH Drugs Sales Volume by Application
  7. 5.2.1 Global Oral GnRH Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oral GnRH Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Oral GnRH Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Oral GnRH Drugs Sales Value by Application
  11. 5.3.1 Global Oral GnRH Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Oral GnRH Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Oral GnRH Drugs Sales Value Share by Application (2021-2032)
6 Oral GnRH Drugs Regional Sales and Value Analysis
  1. 6.1 Global Oral GnRH Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral GnRH Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Oral GnRH Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Oral GnRH Drugs Sales by Region (2027-2032)
  5. 6.3 Global Oral GnRH Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral GnRH Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral GnRH Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral GnRH Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Oral GnRH Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral GnRH Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Oral GnRH Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral GnRH Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Oral GnRH Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral GnRH Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral GnRH Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral GnRH Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Oral GnRH Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral GnRH Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral GnRH Drugs Sales Value Share by Country, 2025 VS 2032
7 Oral GnRH Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Oral GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral GnRH Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral GnRH Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Oral GnRH Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Oral GnRH Drugs Sales by Country (2027-2032)
  6. 7.4 Global Oral GnRH Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral GnRH Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral GnRH Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral GnRH Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral GnRH Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral GnRH Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Oral GnRH Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Oral GnRH Drugs Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Abbvie
  8. 8.2.1 Abbvie Company Information
  9. 8.2.2 Abbvie Business Overview
  10. 8.2.3 Abbvie Oral GnRH Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbvie Oral GnRH Drugs Product Portfolio
  12. 8.2.5 Abbvie Recent Developments
  13. 8.3 Sumitomo Pharma
  14. 8.3.1 Sumitomo Pharma Company Information
  15. 8.3.2 Sumitomo Pharma Business Overview
  16. 8.3.3 Sumitomo Pharma Oral GnRH Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sumitomo Pharma Oral GnRH Drugs Product Portfolio
  18. 8.3.5 Sumitomo Pharma Recent Developments
  19. 8.4 ObsEva
  20. 8.4.1 ObsEva Company Information
  21. 8.4.2 ObsEva Business Overview
  22. 8.4.3 ObsEva Oral GnRH Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ObsEva Oral GnRH Drugs Product Portfolio
  24. 8.4.5 ObsEva Recent Developments
  25. 8.5 JW Pharmaceutical
  26. 8.5.1 JW Pharmaceutical Company Information
  27. 8.5.2 JW Pharmaceutical Business Overview
  28. 8.5.3 JW Pharmaceutical Oral GnRH Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 JW Pharmaceutical Oral GnRH Drugs Product Portfolio
  30. 8.5.5 JW Pharmaceutical Recent Developments
  31. 8.6 ASKA Pharmaceutical
  32. 8.6.1 ASKA Pharmaceutical Company Information
  33. 8.6.2 ASKA Pharmaceutical Business Overview
  34. 8.6.3 ASKA Pharmaceutical Oral GnRH Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 ASKA Pharmaceutical Oral GnRH Drugs Product Portfolio
  36. 8.6.5 ASKA Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral GnRH Drugs Value Chain Analysis
  2. 9.1.1 Oral GnRH Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral GnRH Drugs Sales Mode & Process
  6. 9.2 Oral GnRH Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral GnRH Drugs Distributors
  9. 9.2.3 Oral GnRH Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst